Relation of glycemic control to diabetic complications and health outcomes

Diabetes Care

Volumn 21, Issue 12 SUPPL., 1998, Pages

  Klein, Ronald ^a   Klein, Barbara E K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN;

CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0031729819     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.3.c39     Document Type: Conference Paper

References (17)

1. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260:2864-2871, 1988
2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Reichard P, Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
4. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shiahir M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized, prospective 6 year study Diabetes Res Clin Pract 28:103-117, 1995
5. The University Group Diabetes Program: Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. Diabetes 31 (Suppl. 5): 1-81, 1982
6. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
7. Klein R, Klein BEK, Moss SE, DeMets DL, Kaufman I, Voss PS: Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol 119:54-61, 1984
8. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
9. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthdmol 102:527-532, 1984
10. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154:2169-2178, 1994
11. Klein R, Klein BEK, Moss SE: Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 124:90-96, 1996
12. Ware JE: SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA, Health Institute, New England Medical Center, 1993
13. Wenneker MB: The impact of diabetes severity on quality of life: results from the Medical Outcomes Study (Abstract). Clin Res 39:612A, 1991
14. Weinberger M, Kirkman MS, Samsa GP, Cowper PA, Shortliffe EA, Simel DL, Feussner JR: The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus. Med Care 29:1173-1181, 1994
15. Nerenz DR: Ongoing assessment of health status in patients with diabetes mellitus, Med Care 30 (Suppl. 5):MS112-MS124, 1992
16. American Diabetes Association: Standards of medical care for patients with diabetes mellitus. Diabetes Care 18 (Suppl. 1):8-15, 1995
17. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The medical management of hyperglycemia over a 10-year period in people with diabetes. Diabetes Care 19:744-750, 1996